Keywords
How to Cite
Abstract
The aim of the study. To investigate in experimental conditions the effect of bismuth citrate on the immune system of laboratory animals.
Material and methods. One-time sensitization of tadpoles (subcutaneously into the ear) was performed according to the method of O.G. Alekseeva, A.I. Petkevich. The degree of sensitization was established after skin tests. Determined the leucocyte blood formula, T and B lymphocytes in peripheral blood by the rosette method, immunoglobulins of class A, M, G in serum - by the method of radial immunodiffusion of globulines in agar Difco, circulating and extracellular complexes detection of the response of blood cells to the allergen "in vitro" - by the reaction of specific leukocyte lysis.
Results. Bismuth citrate causes impaired immunological homeostasis in experimental animals. Indicators of nonspecific cellular component of the immune system have changed significantly, characterizing immunocomplex pathology. A decrease in the T-helper subpopulation was observed, indicating a significant immunomodulatory ability of bismuth citrate. At the same time, there was a significant increase in cells capable of rosette formation, which suggests that bismuth citrate is capable of provoking sensitization of the body. In the humoral immunity link, significant differences in the content of circulating immune complexes in sensitized and control animals were observed. Immunoglobulin levels were unchanged relative to control. The analysis of the sensitizing effect indicates that the most probable result of sensitization of the organism in this mode of receipt of bismuth citrate is the formation of type III hypersensitivity.
Conclusions. Bismuth citrate under experimental conditions causes changes in the immune system of experimental animals, which are characteristic of the allergenic response of the organism to the complement-dependent type.
References
Hrynevych, YU.A., Alferov, A.N. (1981). Opredelenye ymmunnykh kompleksom v krovy onkolohycheskykh bolnykh [Determination of immune complex in blood of cancer patients]. Laboratory Case, 8, 493-495.
Trakhtenberh, I.M., Dmytrukha, N.M., Molozhava, O.S., Myronyuk YU.M. (2007). Porushennya imunnoho statusu orhanizmu lyudyny za diyi khimichnykh chynnykiv ta metody yikh vyznachennya: Metod. Rekomendatsiyi [Violation of the immune status of the human body by the action of chemical factors and methods for their determination: Method. Recommendations]. K., 48 p.
Poryadok provedennya naukovymy ustanovamy doslidiv, eksperymentiv na tvarynakh: Nakaz Ministerstva osvity, nauky, molodi ta sportu Ukrayiny vid 01.03.2012 № 249. [ Procedure for carrying out experiments, experiments on animals by scientific institutions: Order of the Ministry of Education, Science, Youth and Sports of Ukraine No. 249 of 01.03.2012 ]. (2012).
Alekseyeva, O.G., Duyeva, L.A. (1978). Allergiya k promyshlennym khimicheskim soyedineniyam [Allergy to industrial chemical compounds]. M.: Meditsina.
Metodicheskiye rekomendatsii № 2121-80 Postanovka issledovaniy po gigiyenicheskomu normirovaniyu promyshlennykh allergenov v vozdukhe rabochey zony: Utv. Zamestitel' Glavnogo gosudarstvennogo sanitarnogo vracha CCCR ot 23.01.1980. [Methodical recommendations No. 2121-80 Research design for hygienic regulation of industrial allergens in the air of the working area: Approved. Deputy Chief State Sanitary Doctor of the USSR CCR dated 01/23/1980.] (1980).
European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes (1986). Available at: http: www.conventions.coe.int/treaty/en/treaties/html/123.htm.
Glantz S. A., Bryan K. S. (1990). Primer of Applied Regression and Analysis of Variance. New York: McGraw-Hill, Health Professions Division.
Salvador J. A., Figueiredo S. A., Pinto R. M., Silvestre S. M. (2012). Bismuth compounds in medicinal chemistry. Future Med Chem., 4, 11, 1495–1523.
Udalova T. A., Logutenko O. A., Timakova E. V., Afonina L. I., Naydenko E. S., Yukhin, Y. M. (2008). Bismuth compounds in medicine. Third International Forum on Strategic Technologies. Tomsk.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.